101 related articles for article (PubMed ID: 12072153)
1. Acute gliclazide administration enhances glucose and ketone body utilization in the perfused hind limb of normal and streptozotocin-diabetic rats.
Okuda Y; Kobayashi K; Ohmori H; Sone H; Suzuki M; Ma J; Nakajima T; Yamada N; Yamashita K
Life Sci; 2002 Jun; 71(6):647-54. PubMed ID: 12072153
[TBL] [Abstract][Full Text] [Related]
2. Effect of insulin and gliclazide on glucose utilization by a perfused intestine-pancreas preparation isolated from diabetic and non-diabetic rats.
Tormo MA; Gomez-Zubeldia MA; Ropero F; Campillo JE
Acta Diabetol; 1994 Sep; 31(3):151-5. PubMed ID: 7827354
[TBL] [Abstract][Full Text] [Related]
3. Ketone body utilization and its metabolic effect in resting muscles of normal and streptozotocin-diabetic rats.
Okuda Y; Kawai K; Ohmori H; Yamashita K
Endocrinol Jpn; 1991 Jun; 38(3):245-51. PubMed ID: 1838977
[TBL] [Abstract][Full Text] [Related]
4. The in vivo interaction between gliclazide and glibenclamide and insulin on glucose disposal in the rat.
Tanira MO; Furman BL
Pharmacol Res; 1999 May; 39(5):349-56. PubMed ID: 10328992
[TBL] [Abstract][Full Text] [Related]
5. Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin.
Portha B; Serradas P
Am J Med; 1991 Jun; 90(6A):15S-21S. PubMed ID: 1831320
[TBL] [Abstract][Full Text] [Related]
6. Gliclazide treatment of streptozotocin diabetic rats restores GLUT4 protein content and basal glucose uptake in skeletal muscle.
Pulido N; Suarez A; Casanova B; Romero R; Rodriguez E; Rovira A
Metabolism; 1997 Dec; 46(12 Suppl 1):10-3. PubMed ID: 9439552
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the anti-diabetic effects of resveratrol, gliclazide and losartan in streptozotocin-induced experimental diabetes.
Yazgan ÜC; Taşdemir E; Bilgin HM; Deniz Obay B; Şermet A; Elbey B
Arch Physiol Biochem; 2015; 121(4):157-61. PubMed ID: 26161595
[TBL] [Abstract][Full Text] [Related]
8. Normalization of impaired glucose tolerance by the short-acting hypoglycemic agent calcium (2S)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl)propionate dihydrate (KAD-1229) in non-insulin-dependent diabetes mellitus rats.
Ohnota H; Koizumi T; Kobayashi M; Momose Y; Sato F
Can J Physiol Pharmacol; 1995 Jan; 73(1):1-6. PubMed ID: 7600439
[TBL] [Abstract][Full Text] [Related]
9. Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats.
Mahfoz AM; El-Latif HA; Ahmed LA; Hassanein NM; Shoka AA
Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1315-1324. PubMed ID: 27612855
[TBL] [Abstract][Full Text] [Related]
10. Effect of aqueous extract of Cyamopsis tetragonoloba Linn. beans on blood glucose level in normal and alloxan-induced diabetic rats.
Mukhtar HM; Ansari SH; Ali M; Bhat ZA; Naved T
Indian J Exp Biol; 2004 Dec; 42(12):1212-5. PubMed ID: 15623233
[TBL] [Abstract][Full Text] [Related]
11. Phosphatidylinositol 3-kinase activation is required for sulfonylurea stimulation of glucose transport in rat skeletal muscle.
Rodríguez E; Pulido N; Romero R; Arrieta F; Panadero A; Rovira A
Endocrinology; 2004 Feb; 145(2):679-85. PubMed ID: 14563700
[TBL] [Abstract][Full Text] [Related]
12. Fisetin improves glucose homeostasis through the inhibition of gluconeogenic enzymes in hepatic tissues of streptozotocin induced diabetic rats.
Prasath GS; Pillai SI; Subramanian SP
Eur J Pharmacol; 2014 Oct; 740():248-54. PubMed ID: 25064342
[TBL] [Abstract][Full Text] [Related]
13. The differential effect of insulin in vivo on the peripheral utilization of glucose and ketone bodies in the rat.
Herndon CM; Schade DS; Eaton RP
Horm Metab Res; 1979 Apr; 11(4):270-5. PubMed ID: 110659
[TBL] [Abstract][Full Text] [Related]
14. Sulphonylurea stimulates glucose uptake in rats through an ATP-sensitive K+ channel dependent mechanism.
Pulido N; Casla A; Suárez A; Casanova B; Arrieta FJ; Rovira A
Diabetologia; 1996 Jan; 39(1):22-7. PubMed ID: 8720599
[TBL] [Abstract][Full Text] [Related]
15. Effect of gliclazide treatment on insulin secretion and beta-cell mass in non-insulin dependent diabetic Goto-Kakisaki rats.
Dachicourt N; Bailbé D; Gangnerau MN; Serradas P; Ravel D; Portha B
Eur J Pharmacol; 1998 Nov; 361(2-3):243-51. PubMed ID: 9865514
[TBL] [Abstract][Full Text] [Related]
16. Probiotic treatment reduces blood glucose levels and increases systemic absorption of gliclazide in diabetic rats.
Al-Salami H; Butt G; Fawcett JP; Tucker IG; Golocorbin-Kon S; Mikov M
Eur J Drug Metab Pharmacokinet; 2008; 33(2):101-6. PubMed ID: 18777945
[TBL] [Abstract][Full Text] [Related]
17. Effect of gliclazide on the functional response to calcium in diabetic rat heart.
Shinzato T; Shimabukuro M; Higa S; Nagamine F; Murakami K; Takasu N
Gen Pharmacol; 1996 Apr; 27(3):471-5. PubMed ID: 8723529
[TBL] [Abstract][Full Text] [Related]
18. Gliclazide attenuates the intracellular Ca2+ changes induced in vitro by ischemia in the retinal slices of rats with streptozotocin-induced diabetes.
Kinukawa J; Shimura M; Harata N; Tamai M
Curr Eye Res; 2005 Sep; 30(9):789-98. PubMed ID: 16146925
[TBL] [Abstract][Full Text] [Related]
19. Effect of pioglitazone on expression of hypoxia-inducible factor 1α and vascular endothelial growth factor in ischemic hindlimb of diabetic rats.
Zhang M; Gao X; Bai SJ; Ye XM; Zhang J
Eur Rev Med Pharmacol Sci; 2014; 18(9):1307-14. PubMed ID: 24867508
[TBL] [Abstract][Full Text] [Related]
20. Antidiabetic effect of S-allylcysteine: Effect on plasma and tissue glycoproteins in experimental diabetes.
Saravanan G; Ponmurugan P; Senthil Kumar GP; Rajarajan T
Phytomedicine; 2010 Dec; 17(14):1086-9. PubMed ID: 20576413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
